Back
Telomir Pharmaceuticals, Inc. 10K Form
Sell
40
TELO
Telomir Pharmaceuticals, Inc.
Last Price:
$1.39
Seasonality Move:
27.19%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TELO News And Ratings
See the #1 stock for the next 7 days that we like better than TELO
TELO Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-927.3K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.21 |
| Price / Book: | 6.95 |
Profitability
| EPS (TTM): | -0.37360 |
|---|---|
| Net Income (TTM): | $-11.3M |
| Gross Margin: | $0 |
| Return on Equity: | -670.91% |
| Return on Assets: | -507.28% |
Telomir Pharmaceuticals, Inc. Earnings Forecast
Key Telomir Pharmaceuticals, Inc. Financial Ratios
-
Per Share Earnings over the last 4 years have been positive in 0 years.
Telomir Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | TELO |
| Website: | telomirpharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 17.51 |
| Quick Ratio: | 17.34 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TELO Technical Analysis vs Fundamental Analysis
Sell
40
Telomir Pharmaceuticals, Inc. (TELO)
is a Sell
Is Telomir Pharmaceuticals, Inc. a Buy or a Sell?
-
Telomir Pharmaceuticals, Inc. stock is rated a SellThe current Telomir Pharmaceuticals, Inc. [TELO] share price is $1.41. The Score for TELO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.